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Background: The objectives of the study were to characterize the expression of the α- and β-subunits of
granulocyte-macrophage colony stimulating factor (GM-CSF) receptor in bovine cumulus cells and oocytes and to
determine the effect of exogenous GM-CSF on cumulus cells expansion, oocyte maturation, IGF-2 transcript
expression and subsequent competence for embryonic development.
Methods: Cumulus-oocyte complexes (COC) were obtained by aspirating follicles 3- to 8-mm in diameter with an
18 G needle connected to a vacuum pump at −50 mmHg. Samples of cumulus cells and oocytes were used to
detect GM- CSF receptor by immunofluorescence. A dose–response experiment was performed to estimate the
effect of GM-CSF on cumulus cell expansion and nuclear/cytoplasmic maturation. Also, the effect of GM-CSF on
IGF-2 expression was evaluated in oocytes and cumulus cells after in vitro maturation by Q-PCR. Finally, a batch of
COC was randomly assigned to in vitro maturation media consisting of: 1) synthetic oviductal fluid (SOF, n = 212);
2) synthetic oviductal fluid supplemented with 100 ng/ml of GM-CSF (SOF + GM-CSF, n = 224) or 3) tissue culture
medium (TCM 199, n = 216) and then subsequently in vitro fertilized and cultured for 9 days.
Results: Immunoreactivity for both α and β GM-CSF receptors was localized in the cytoplasm of both cumulus cells
and oocytes. Oocytes in vitro matured either with 10 or 100 ng/ml of GM-CSF presented a higher (P < 0.05)
cumulus cells expansion than that of the control group (0 ng/ml of GM-CSF). GM-CSF did not affect the proportion
of oocytes in metaphase II, cortical granules dispersion and IGF-2 expression. COC exposed to 100 ng/ml of GM-CSF
during maturation did not display significant differences in terms of embryo cleavage rate (50.4% vs. 57.5%),
blastocyst development at day 7 (31.9% vs. 28.7%) and at day 9 (17.4% vs. 17.9%) compared to untreated control
(SOF alone, P = 0.2).
Conclusions: GM-CSF enhanced cumulus cell expansion of in vitro matured bovine COC. However, GM-CSF did not
increase oocyte nuclear or cytoplasmic maturation rates, IGF-2 expression or subsequent embryonic development.
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The granulocyte-macrophage colony stimulating factor
(GM-CSF) is a glycoprotein with several molecular-
weight species ranging from 18 to 30 kDa [1]. Its recep-
tor is comprised of two cytokine-specific α-subunits and
two signal transducing β-subunits [2]. Upon binding, the
GM-CSF-receptor complex is capable of stimulating
proliferation, maturation and viability of hematopoietic
and non-hematopoietic cells [3,4]. The interaction of
GM-CSF with its receptor stimulates multiple signal
transduction pathways, including Jak/STAT pathway,
Ras/Raf/mitogen-activated protein kinase pathway, phos-
phatidylinositol 3-kinase (PI 3-kinase)/protein kinase B
(PKB) pathway, and protein kinase C (PKC) pathway [5].
GM-CSF promote glucose uptake through PI 3-kinase/
PKB pathway via translocation of glucose transporter 1
(GLUT 1) [4]. GM-CSF induction of the PKB/Akt path-
way results in direct cell survival activity and inactivation
of proapoptotic factors BAD, caspase 9 and forkhead [6].
Additionally, Akt promotes cell survival indirectly by
regulating a number of processes involved in glucose
metabolism [6].
Both GM-CSF and its receptor have been highly charac-
terized in the hematopoietic cell line, as well as in other
cell types including fibroblasts, oligodendrocytes, tropho-
blast, endothelial and neoplastic [7-10]. In reproductive
tissues, GM-CSF has been detected in testis, placenta,
uterus, oviduct and ovary [11-15]. GM-CSF is expressed
in utero by luminal and glandular epithelial cells and is
subsequently secreted into the uterine lumen where
activates neutrophils and macrophages during estrous
cycle and early pregnancy [14,16]. The GM-CSF receptor
has been detected from the fertilized oocyte through
blastocysts stage in both mice and humans [17]. The se-
lective expression of GM-CSF in theca, granulosa and
lutheal cells coincides with peak follicular development,
ovulation and luteinization [18-20]. In mice, cumulus-
oocytes complexes (COC) express mRNA for the α-subunit
of GM-CSF receptor, which has been reported to facilitates
glucose uptake and thereby promote viability and prolifera-
tion in certain cell lineages [21]. Changes in estrogen and
progesterone concentrations regulate the production of
GM-CSF which suggests a potential regulatory function
during the estrus cycle [14]. Thus, the expression of GM-
CSF in the mouse ovary and uterus and its steroidogenic
regulation suggest an autocrine/paracrine role in the
ovarian physiology and embryonic development.
Oogenesis relies on the highly coordinated interaction
between the oocyte and surrounding cells; the oocyte reg-
ulates follicular cell proliferation and differentiation and
follicular cells control oocyte meiotic arrest [22,23]. Inter-
action of cumulus with the oocyte provides local produc-
tion of glycosaminoglycans, steroid hormones, nutrients
and other factors that support oocyte maturation [24-26].Thereafter, presence of cumulus cells during IVF enhances
fertilization and embryo development rates by facilitating
sperm selection, capacitation, acrosome reaction and
penetration [24]. Most of the energy required for these
processes is supplied by glycolysis. However, glycolysis is
limited during oogenesis due to reduced glucose transport
and hexokinase activity in the oocyte [27]. In vitro studies
have shown that cumulus cells are able to uptake and
metabolize glucose allowing transport of glycolytic prod-
ucts such as pyruvate and lactate through gap junctions
into the oocyte [28]. Pyruvate and lactate are easily
oxidized by the oocyte becoming the main energy source
during maturation [27,29]. Glucose might also be meta-
bolized through the pentose-phosphate pathway (PPP)
playing an important role in nucleotide biosynthesis and
glutathione reduction during meiotic maturation and
pronuclear formation [29]. Moreover, hyaluronic acid
formation during cumulus expansion requires conversion
of glucose into extracellular matrix components including
glutamine [30]. Thus, the effect of GM-CSF on cumulus
cells may potentially result in higher glucose uptake and
cell proliferation or survival enhancing cumulus expan-
sion. Alternatively, GM-CSF produced by macrophages
within the ovarian stroma and theca cell layer may influ-
ence steroidogenesis and differentiation of thecal and
follicular cells [20]. Taking these data together, we hypo-
thesized that GM-CSF activity in the bovine COC may
enhance oocyte maturation, cumulus expansion and sub-
sequent embryonic development. To estimate the poten-
tial effect of GM-CSF at the transcription level, the
expression of IGF-2 may be quantified in bovine cumulus
and oocytes after IVM. IGF-2 is an imprinted gene in vari-
ous mammal species and encodes an essential growth fac-
tor that plays a crucial role in tissue differentiation, fetal
growth, and placental development [31]. In addition, IGF-
2 is believed to stimulate granulosa cells to produce estra-
diol, enhancing oocyte maturation [32].
The first objective of the current study was to cha-
racterize the expression of the α- and β-subunits of the
GM- CSF receptor in bovine cumulus cells and oocytes.
The second objective was to estimate the effect of exogen-
ous GM-CSF on nuclear and cytoplasmic oocyte matur-
ation, cumulus expansion, IGF-2 transcript expression and
subsequent competence for embryonic development.
Methods
Collection of oocytes and cumulus cells
All cell culture reagents were obtained from Sigma, un-
less otherwise specified. Bovine ovaries were obtained
from a local abattoir and transported to the laboratory
immersed in 0.85% saline supplemented with 100 mg/
ml of Streptomycin and 80 mg/mL Sodium Penicillin G
at a temperature of 35–38°C within 3 h of collection.
Cumulus-oocyte complexes (COC) were obtained by
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needle connected to a vacuum pump at −50 mmHg.
The follicular fluid was deposited in 60-ml tubes
containing PBS-Dulbecco (8 mg/ml NaCl, 0.2 mg/ml
KCl, 1.15 mg/ml KH2PO4, 0.10 mg/ml MgCl2 + 6H2O,
0.10 mg/ml CaCl2, 0.036 mg/ml sodium pyruvate,
1.00 mg/ml glucose) supplemented with BSA (3 mg/ml)
and gentamicin (50 μg/ml).
Immunofluorescence for GM-CSF detection in bovine
oocytes and granulosa cells
Granulosa cells and oocytes were washed in 0.1 M PBS
(pH 7.4, Gibco BRL) and fixed in a mixture of Histochoice
and ethanol (4:1). Cumulus cells were obtained by
vortexing COC for 5 minutes in PBS-0.1% BSA. Cells were
then permeabilized and blocked in a solution of 0.1 M
PBS with 1% BSA, 5% skim milk and 0.3% Triton X-100
for 60 min at room temperature. Cells were incubated in
blocking solution (without Triton X-100) containing poly-
clonal antibodies (1:200; N-20 and C-18 for the GM-CSF
alpha and beta subunit receptors respectively, Santa Cruz
Biotechnology, California, USA) raised against the carb-
oxyl and amino terminals of the α- and β-GM-CSF recep-
tor subunits, respectively. After three washes with PBS,
cells were incubated with anti-rabbit, anti-goat and anti-
mouse IgGs (1:300 in blocking buffer) conjugated to Alexa
Fluor 488 and 594 nm (Molecular Probes, California, USA),
respectively. Cells were again washed three times in PBS and
mounted under coverslips in a solution containing 4’, 6-
diamidino-2-phenylindole (DAKO Laboratories, Denmark).
Samples were examined under confocal microscope and
photos were obtained using photomicroscopy (Olympus
Fluoview 1000, Tokyo, Japan).
In vitro maturation of cumulus oocyte complexes
After follicular aspiration, COC were classified into five
groups based on the morphology of their surrounding
cumulus cells [33]. Group A: with many layers of com-
pact cumulus cells; Group B: with partially removed
cumulus cells; Group C: denuded oocytes; Group D:
degeneration of oocyte cytoplasm; Group E: expanded
cumulus cells. Only COC classified as Group A and B
were used in this study. Cumulus-oocyte complexes
were then washed twice in PBS-Dulbecco (Gibco BRL)
and twice in maturation media according to each treat-
ment. Maturation media consisted of SOF (107.7 mM
NaCL, 7.16 mM KCl, 1.19 mM KH2PO4, 1.5 mM D-
glucose, 5 mM Taurine, 1.71 mM CaCL2, 0.49 mM
MgCl2, 3.3 mM Sodium lactate and 25.07 mM NaHCO3)
at pH 7.4 supplemented with aminoacids BME 50×
(20 μl/ml), MEM 100x (10 μl/ml), BSA FV (8 mg/ml)
and gentamicin (50 μg/ml). Cumulus oocyte complexes
were randomly assigned to SOF medium supplemented
with Recombinant human GM-CSF (hGM-CSF 215-GM-010 (R&D System, Inc., Minneapolis, USA) at con-
centrations of 1 (n = 71), 10 (n = 59) and 100 ng/ml (n =
89) [0.07, 0.7 and 7 nM, respectively]. Two additional
groups were incorporated in the experimental design:
SOF alone (n = 75) and a positive control maturation
media consisted of tissue culture medium (n = 95)
[TCM; 15 mg/ml TCM 199, 2.2 mg/ml NaHCO3 at
pH 7.4] supplemented with 10% FBS (Hyclone, Utah,
USA), 0.2 μM Pyruvate, 5 μg/ml LH (Lutropin, Bioniche,
Belleville, Canada), 40 mg/ml FSH (Folltropin, Bioniche,
Bellevile, Canada) and 50 μg/ml gentamicin.
Groups of 10–15 COC were allocated for in vitro ma-
turation (IVM) in 50-μl droplets of treatment media in
Petri dishes under mineral oil for 22 h in humidified at-
mosphere consisting in 5% CO2 at 38.5°C.Assessment of cumulus expansion and oocyte nuclear
maturation
After 22 h of IVM, oocytes were collected and evaluated
according to the cumulus expansion and then nuclear
maturation. Cumulus expansion was determined using
three different methods: 1) higher and a lower diameter
for each COC were measured using a micrometric rule
previously calibrated using a 0.1 mm objective (Nikon);
2) oocytes were microphotographed and higher and
lower diameters were measured using a Fluoview software
(FV 1000-ASW 1.4.3; Olympus, Corporation, Japan); and
3) a subjective scale was used [34] to estimate the degree
of cumulus expansion. The degree of cumulus expansion
was measured as follows: 0, no expansion; +1, separation
of only the outermost layer of cumulus cells; + 2, further
expansion involving the outer half of the cumulus
oophorus; +3, further expansion up to, but not including,
the corona radiate; +4, complete expansion, including the
innermost corona radiate cells. A cumulus expansion
index (CEI) [35] was calculated according to the subjective
scale previously described using the following formula:
CEI = (+1xn) + (+2xn) + (+3xn) + (+4xn) / N. Where CEI
is the index for a given treatment, n is the total number of
COC observed for each scale value in each treatment and
N is the total number of COC in each treatment.
After cumulus expansion evaluation, cumulus cells
were removed mechanically by vortex in PBS-0.1% BSA
and washed twice in the same solution. Oocytes were
placed between glass and cover slides with silicone and
fixed with a mixture of acetic acid and ethanol (1:3)
overnight at room temperature. Oocytes were then
stained using 1% aceto-orcein for 1 h and destained
using a mixture of acetic acid, glycerol and distilled
water (1:1:3). Stained oocytes were examined under a
phase contrast microscope for intact nucleus with ger-
minal vesicle (GV), germinal vesicle breakdown (GVBD)
or metaphase II (MII)-arrested.
Figure 1 Expression of GM-CSF α and β receptors in bovine cumulus cells. Confocal microscopy analysis was performed using anti-GM-CSFrα
and anti-GM-CSFrβ antibodies. A, B: Specimen incubated without the first (primary) antibody showed no signal. C, D: GM-CSFrα subunit (green).
E, F: GM-CSFrβ subunit (green). Cell nuclei were stained using propidum iodide (red). Scale bar = 10 μm.
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Cumulus oocyte complexes (n = 52-60/per group) were
randomly assigned to the following in vitro maturation
media: SOF alone, SOF supplemented with GM-CSF at a
concentration of 1, 10 or 100 ng/ml of GM-CSF or
TCM 199 as described above. Groups of 10–15 COC
were allocated for in vitro maturation (IVM) in 50-μl
droplets of treatment media in Petri dishes under min-
eral oil for 22 h in humidified atmosphere consisting of
5% CO2 at 38.5°C. An additional sample of COC (n =
40-45/per group) was in vitro matured in SOF medium
alone or supplemented with 10 and 100 μM of
LY294002 a PI 3-kinase inhibitor or DMSO (DMSO wasused as a diluent control). Cumulus cells were removed
mechanically by vortex in PBS-0.1% BSA at 22 h. A
50 μl aliquot of cell suspension was mixed with 5 μl of
Trypan Blue for cell viability using a Neubauer chamber.
Assessment of oocyte cytoplasmic maturation
Cumulus oocyte complexes were randomly assigned to the
following in vitro maturation media: 1- SOF without GM-
CSF supplementation (n = 123), 2- SOF supplemented with
100 ng/ml of GM-CSF or 3- TCM 199 as described above
(n = 159).
Immunohistochemical staining for cortical granules
was also performed for evaluation of oocyte cytoplasm
Figure 2 Expression of GM-CSF α and β receptors in bovine COC. Confocal microscopy analysis was performed using anti-GM-CSFrα and
anti-GM-CSFrβ antibodies. (A, B) Specimen incubated without the first (primary) antibody showed no signal. C, D: GM-CSFrα subunit (green).
E, F: GM-CSFrβ subunit (green). Oocyte nuclei were stained using propidum iodide (red). Scale bar = 100 μm.
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gates; type II, aggregates with some dispersion and type
III, dispersion of granules) was evaluated as previously
described [36]. Briefly, the zona pellucida was removed
using 0.5% (w/v) pronase and oocytes were fixed in 4%
(w/v) paraformaldehyde for 30 minutes. Oocytes were
permeabilized with 0.25% Triton X-100 and washed with
blocking solution (PBS containing 2% (w/v) BSA, 2%
non-fat milk and 0.15 M glycine). Staining was
performed using 10 mg/ml lens culinaris conjugated to
fluorescein isothiocyanate (FITC, Sigma L9267, St Louis,
USA).Oocytes were examined and evaluated under epi-
fluorescence inverted microscope (Nikon Corporation,
Tokyo, Japan).
Quantitative PCR
Relative expression of IGF-2 gene transcript in bovine cu-
mulus cells and oocytes were determined in COC (n = 30
per group) in vitro matured in TCM, SOF alone or sup-
plemented with 100 ng/ml of GM-CSF. Total RNA was
extracted from lysed cells using the RNAeasy extraction
mini kit (Qiagen Inc., Valencia, CA, USA). All subsequent
RNA purification steps were carried out according to the
Table 1 Dose–response effect of the GM-CSF on nuclear maturation of bovine oocytes matured in vitro
Treatment COC GV GVBD MI MII
(n) (%) (%) (%) (%)
SOF 75 11/78 (14.6) 9/75 (12.0) 14/75 (18.7) 41/75 (54.7)
SOF + GM-CSF (1 ng/ml) 71 11/71 (15.5) 5/71 (7.0) 13/71 (18.3) 42/71 (59.2)
SOF + GM-CSF (10 ng/ml) 59 8/59 (13.6) 4/59 (6.8) 15/59 (25.4) 32/59 (54.2)
SOF + GM-CSF (100 ng/ml) 89 14/89 (15.7) 4/89 (4.5) 18/89 (20.2) 53/89 (59.6)
TCM 95 1/95 (1.0) 4/95 (4.2) 11/95 (11.6) 79/95 (83.2*)
GV Germinal Vesicle, GVBD Geminal Vesicle Break-Down, MI metaphase I.
MII metaphase II. (*) Indicate significant differences between treatments (P < 0.05).
(There were 3 replicates for this experiment).
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the oligo-dT method (Promega Corp., Madison, WI, USA)
with 1 μg of total RNA as a template in a reaction volume
of 20 μl. Sequences of forward and reverse bovine IGF-2
were: ATCCAGCCGCATAAACCG and GGACGGTACA
GGGATTTCAG. A reaction mixture containing a volume
of 50 μl was prepared (5 μl 10× PCR buffer, 2 μl dNTPs
mix 10 mM, 2.5 μl forward and reverse primers 10 μM,
molecular biology grade water and 0.5 μl Taq DNA poly-
merase). All the reagents were acquired from Promega.
The reaction was heated on a Stratagene Thermo Cycler
(GRI Systems, UK) to 95°C for 7 min, followed by 35 cycles
of 94°C for 30 s, 55°C for 30 s, 72°C for 1 min, and a final
extension step of 72°C for 10 min. As a normalization
control for RNA loading, parallel reactions in the same
multiwell plate were performed using GAPDH as a target.
Quantification of gene amplification was made following
quantitative PCR by determining the threshold cycle (CT)
number for SYBR fluorescence within the geometric re-
gion of the semilog plot generated during PCR. Within
this region of the amplification curve, each difference of
one cycle is equivalent to a doubling of the amplified
product of the PCR. The relative quantification of the tar-
get gene expression across treatment was evaluated using
the comparative ΔΔCT method. The CT value was deter-
mined by subtracting the GAPDH CT value from the tar-
get CT value of the sample. Calculation of ΔΔ CT involved
using target gene expression on immature control (sample
with the highest CT value or lowest target expression) as
an arbitrary constant to subtract from all other CT sampleTable 2 Effect of the GM-CSF factor on the type of cortical gr
matured bovine oocytes
Treatment COC Type I
(n) (%)
SOF 123 37/123
SOF + GM-CSF (100 ng/ml) 133 42/133
TCM* 159 28/159
a,b,c Different superscripts within columns indicate significant difference (P < 0.05).
(There were 4 replicates for this experiment).values. Relative target mRNA expression was calculated as
fold changes in relation to immature control sample and
expressed as 2-ΔΔCT value.
In vitro fertilization and embryo development
A sample of COC was randomly assigned to in vitro mat-
uration media consisting of: 1) SOF alone (SOF, n = 212);
2) SOF supplemented with 100 ng/ml of GM-CSF (SOF +
GM-CSF, n = 224) or 3) Tissue Culture Medium (TCM
199, n = 216) and then subsequently in vitro fertilized and
cultured for 9 days.
Embryos were produced using standard protocols for
in vitro maturation, fertilization and culture [36-39].
Frozen-thawed semen from bulls of proven fertility (ABS,
American Breeders Service, DeForest, WI, USA) was used
for in vitro fertilization (IVF). The content of one 0.25-ml
straw of frozen Holstein Friesian semen was thawed in
water at 35–37°C. Thawed sperm were washed in a discon-
tinuous gradient of 45/90% Percoll using centrifugation at
700 g for 20 min. The pellet was resuspended with washing
medium TALP (Tyrode’s albumin lactate pyruvate)
containing 6 mg/mL BSA (Fraction V), 1.0 mM Sodium
Pyruvate and 5 μg/mL of gentamicin and centrifuged once
again at 250 g for 5 minutes. After being centrifuged, the
spermatozoa in pellets were counted and the volume ad-
justed to give a concentration of approximately 1.5-2 ×
106 sperm/ml of heparin-containing (1 μg/ml) TALP-
IVF medium (TALP without glucose supplemented with
4 mg/ml BSA, 100 IU/ml penicillin and streptomycin,
0.1 mM pyruvate, and 2 μg/ml heparin). The spermanules dispersion (cytoplasmic maturation) of in vitro
Type II Type III
(%) (%)
(30.1)a 18/123 (14.6)b 68/123 (55.3)c
(31.6)a 23/133 (17.3)b 68/133 (51.1)c
(17.6)a 46/159 (2.9)b 85/159 (53.5)c
Figure 3 Effect of GM-CSF on diameters of cumulus in in vitro matured COC. (A) COC (n = 52-56/per group) were in vitro matured in SOF
medium alone or supplemented with 1, 10 and 100 nM of GM-CSF. (B) Higher (P < 0.001) diameters were detected in COC matured in presence
of 10 and 100 ng/ml of GM-CSF compared to untreated COC. Time 0 corresponds with the immature state of the oocytes. Parameters from
oocytes in the immature state and matured in TCM were used as positive control and not included in the statistical analysis. (*) Indicate
significant (P < 0.001) differences between treatments of 0, 1 and 100 ng/ml of GM-CSF.
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Figure 4 Effect of GM-CSF on cumulus cell in in vitro matured COC. (Left Graphs) COC were matured in SOF medium alone or
supplemented with 1, 10 and 100 nM of GM-CSF. Parameters from cumulus cells derived from oocytes in the immature state and matured in
TCM were used as positive control and not included in the statistical analysis. (Right Graphs) COC were matured in SOF medium supplemented
with GM-CSF, LY294002 (10 or 100 μM) or DMSO. (A, B) Cumulus cell expansion was evaluated subjectively using the cumulus expansion index
(CEI). (C, D) Cell viability was evaluated using Trypan Blue staining. (E, F) Cell number was determined using hemocytometer. (−−−) Corresponds
with the lower limit for cumulus expansion (CEI ≥ 0.5). (*) Indicate significant differences between treatments of 0, 1 and 100 ng/ml of GM-CSF.
*** P < 0.001, ** P < 0.01 and *P < 0.05. (#) Indicate significant differences compared with control ### P< 0.001, ## P< 0.01, # P < 0.05.
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microdrops and covered with mineral oil. Thereafter,
10–12 matured COC per drop were added and incubated
in 5% CO2 and 5% O2 in humidified air at 38.5°C. After
18–20 h, the presumptive zygotes were vortexed in PBS-0
.1% BSA medium to remove the cumulus cells. Denuded
zygotes were cultures in 30 μl of bicarbonate-buffered
SOF medium for 7 days in a humid chamber under an
atmosphere containing 5% CO2, 5% O2 and 90% N2.Embryo development and total cell number of blastocysts
Early cleavage was evaluated on Day 2 after in vitro
fertilization (Day 0 = in vitro fertilization) and blastocyst
formation were recorded on Days 7 and 9 of in vitro
culture. Blastocysts from days 9 of in vitro culture (n = 30/
per group) were used for cell number determination.
Embryos were placed on a slide with dye bisbenzimide
(Bis, Hoechst 33342, 10 μg/ml) for 5 min at 39°C. Hoechst
dye was removed, and cover lips were mounted with wax
Figure 5 Relative expression of IGF-2 gene transcript. (mean ±
SEM) in bovine cumulus cells (black bars) and oocytes (grey bars) in
COC (n = 30/per group) in vitro matured in TCM, SOF alone or
supplemented with 100 ng/ml of GM-CSF. (*) Indicate significant
differences compared with immature control (IC). Different
superscripts (a,b,c) indicate significant (P < 0.05) difference.
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bryo. Staining nuclei was visualized with an epifluores-
cence microscope (Olympus, Tokyo, Japan).Statistical analysis
Single point measurements such as the difference among
treatments for cumulus expansion, nuclear and cytoplas-
mic maturation, and IGF-2 mRNA levels were estimated
using one-way analysis of variance (ANOVA). Tukey’s
multiple comparison was used as a post-hoc test when a
significant difference was detected. Data from cumulus
diameter was normalized to a logarithmic scale in order
to accomplish homocedasticity. CEI and number of cells
values were compared among treatments using non-
parametric Kruskal-Wallis and multicomparison tests.
Data from cellular viability were arcsin-transformed and
analyzed using one-way ANOVA and Tukey’s test. All
statistical analyses were performed using the Statistica
7.0 (StatSoft, Inc., Oklahoma, USA) software package.Table 3 Fertilization and embryo development rates from bo
supplemented with 100 ng/ml of GM-CSF
Treatment Oocytes (n) Cleavage (%) Blastocysts
day 7 (%)
TCM 216 146 (67.6)a 55 (37.7)a
SOF 212 122 (57.5)b 35 (28.7)b
SOF + GM-CSF (100 ng/ml) 224 113 (50.4)b 36 (31.9)b
a,b Different superscripts within columns indicate significant differences (P < 0.05). (TResults
Expression of the GM-CSF receptor in bovine cumulus
cells and oocytes
Immunofluorescence analyses were performed to detect
expression of α and β receptors of GM-CSF in whole-
mounted bovine cumulus cells (Figure 1A-F) and oocytes
(Figure 2A-F). Specimen (cells or oocytes) incubated
without the first (primary) antibody showed no signal
(Figures 1A,B; 2A,B).
Effect of GM-CSF on the bovine oocyte in vitro
maturation
A dose–response experiment was performed to estimate
the effect of GM-CSF on nuclear maturation. The mat-
uration state was evaluated using aceto-orcein staining.
Data showed that the proportion of oocytes undergoing
metaphase II after treatment with 1, 10 or 100 ng/ml of
GM-CSF was not significantly different compared to the
untreated controls (59.2, 54.2, 59.6 and 54.7%, respect-
ively; Table 1). However, a higher proportion of metaphase
II oocytes were found in the TCM treatment (83.2%).
Further analyses were performed to estimate cytoplas-
mic maturation by cytoplasmic granule visualization using
a fluorescence-labeled lectin. Treatment with 100 ng/ml
of GM-CSF resulted in no significant differences in terms
of percentage of type III oocytes compared to untreated or
TCM controls (51.1, 55.3 and 53.5%; Table 2).
Effect of GM-CSF on the bovine cumulus expansion and
cell viability
Cumulus expansion as an indirect indicator of oocyte
maturation was estimated by calculating major diameters
of cumulus and CEI before and after IVM. An increase
(P < 0.001) in cumulus diameter was observed in COC
treated with 10 and 100 ng/ml of GM-CSF (329 ± 68 and
400 ± 88 μm) compared with control COC (0 ng/ml,
295 ± 57 μm; Figure 3). Similarly, determination of CEI
showed that both 10 and 100 ng/ml treatments induced
higher (P < 0.05) cumulus expansion (0.85 and 1.22) after
maturation compared to the untreated control (0.25;
Figure 4A). To test whether GM-CSF has a direct effect
on cumulus expansion, an inhibitor of the PI 3-kinase






60 (41.1)a 27.8a 108.2 ± 7.7
38 (31.1)b 17.9b 98 ± 12.6
39 (34.5)b 17.4b 96 ± 13.1
here were 4 replicates for this experiment).
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http://www.rbej.com/content/11/1/553-kinase inhibitor to GM-CSF treated COC resulted in
lower (P < 0.05) cumulus expansion (0.4 and 0.26) com-
pared to COC matured only with GM-CSF (1.05;
Figure 4B). The DMSO control showed no effect on cu-
mulus expansion. After cumulus evaluation, cumulus
cells were separated individually, stained using Trypan
Blue and counted using a Neubauer chamber. Percen-
tage of live cumulus cells decreased after in vitro matur-
ation from 63.4 ± 14.3% to 45.2 ± 5.3% (Figure 4C).
However, treatment with 10 and 100 ng/ml of GM-CSF
resulted in higher (P < 0.001) percentage of live cells
(57.2 ± 5.9 and 65.1 ±6.6%, respectively) compared to
untreated cells (45.2 ± 5.3%). Treatment with 100 μM of
PI 3-kinase inhibitor and GM-CSF resulted in lower
(P < 0.001) percentage of live cells (41.1 ± 10.3%) com-
pared to cells treated with GM-CSF alone (56.5 ± 13%)
and cells treated with GM-CSF and 10 μM of PI3-kinase
inhibitor (Figure 4D). To determine the potential effect
of GM-CSF on cumulus cell proliferation, the total num-
ber of cells (live and dead) from all treatment groups
were determined as described above (Figure 4E). Total
cell number increased (P < 0.001) after the addition of
100 ng/ml of GM-CSF (147.4%) compared to untreated
control (100%). Treatment with 10 and 100 ng/ml of
GM-CSF resulted in more live cells (63.3%, P < 0.01 and
92.3%, P < 0.001, respectively) compared to the untreated
control (44.5%). The addition of 100 μM of PI 3-kinase
inhibitor in presence of GM-CSF resulted in lower num-
ber of total cells (94.1%, P < 0.01) and live cells (42.3%,
P < 0.01) compared to cells treated with GM-CSF alone
(140.2 ± 13% and 79.3%, Figure 4F).
Furthermore, we evaluated the effect of GM-CSF during
in vitro maturation on the mRNA IGF-2 levels by Q-PCR.
Relative IGF-2 mRNA expression increased (P < 0.05) in
cumulus cells and oocytes after in vitro maturation com-
pared to the immature state. GM-CSF induced no signifi-
cant effect over IGF-2 expression neither in cumulus cells
or oocytes (P > 0.05; Figure 5). However, IGF-2 expression
was up-regulated (P < 0.05) in cumulus cells and oocytes
after maturation in TCM (2.81 and 2.64 fold compared to
the immature control).
Determination of the GM-CSF effect during oocyte
maturation on subsequent embryo development
In order to evaluate the effect of GM-CSF in vitro mat-
uration on subsequent embryonic development we
utilized COC matured in TCM, SOF and SOF + 100 ng/
ml of GM-CSF for in vitro fertilization. Results showed
that COC exposed to 100 ng/ml of GM-CSF during mat-
uration did not display significant differences in terms of
embryo cleavage rate (50.4% vs. 57.5%), blastocyst devel-
opment at day 7 (31.9% vs. 28.7%) and at day 9 (17.4%
vs. 17.9%) or embryonic nuclei count (98 vs. 96) com-
pared to untreated controls (P > 0.05; Table 3). However,oocytes matured in TCM showed higher (P < 0.05) cleav-
age and blastocyst development rates compared to oo-
cytes matured in SOF and in SOF supplemented with
100 ng/ml of GM-CSF.
Discussion
Immunofluorescence analyses demonstrated a wide dis-
tribution of α- and β- subunits of the GM-CSF receptor
in bovine oocytes and cumulus cells. Immunolabeling
associated to both α and β receptors appeared to be
located in the cytoplasm of cumulus cells. Oocytes col-
lected from antral follicles were stripped from cumulus
cells and processed for immunofluorescence analyses.
Confocal microscopy showed a pattern of immunoreac-
tivity for the α receptor in the cytoplasm in proximity to
the plasmatic membrane. In contrast, the β subunit was
homogeneously distributed in the cytoplasm. A previous
report indicated the expression of the α-subunit but not
the β- subunit in mouse COC by RT-PCR [20]. However,
sections of mice and human ovarian tissue analyzed by
in situ hybridization showed the transcript of both α-
and β subunits as well as the GM-CSF ligand in the
oocyte, theca, granulosa and luteal cells [18,19]. More-
over, RT-PCR analysis detected the expression of both
subunits in human granulosa-lutein cell culture prepara-
tions [11]. Giving the abundant expression of GM-CSF
receptor in bovine oocytes and granulosa cells, it is
possible that this cytokine may play a significant role in
the local regulation of the ovarian physiology. Evidence
indicating a functional role of GM-CSF in reproduction
has been provided by studies using GM-CSF knockout
(GM-CSF −/−) mice. These animals exhibited longer
estrous cycles, delayed blastocyst development, smaller
litter size and higher rate of fetal death [40]. However,
the biological role of GM-CSF has recently been associ-
ated to glucose transport in several non-hematopoietic
cells including the spermatozoa [41]. GM-CSF increased
glucose uptake via functional facilitative hexose trans-
porters GLUT improving the freezing/thawing resistance
and subsequent linear motility [12,41]. These finding,
together with observations that GM-CSF and both sub-
units of the GM-CSF receptor are expressed in bovine
oocytes and granulosa cells, suggest that GM-CSF may
activate cumulus expansion and oocyte maturation, en-
hancing subsequent embryonic development. Our data
demonstrates that supplementation of GM-CSF during
in vitro maturation has no effect on the proportion of
oocytes undergoing nuclear or cytoplasmic maturation.
However, supplementation of GM-CSF induced higher cu-
mulus expansion in in vitro matured bovine COC. Inhib-
ition of the phosphatidylinositol 3 (PI3)-kinase prevented
the GM-CSF effect, suggesting that the 3PI-kinase path-
way is associated with glucose uptake, mediated by the
activity of GM-CSF.
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in higher percentage of total cells (45.4% higher) com-
pared to untreated controls. The proportion of nonviable
cells remained similar to controls indicating that a higher
proportion of live cells accounted for the total cells. These
data suggest that GM-CSF induced proliferation instead
of survival of cumulus cells. The proliferative effect of
GM-CSF was blocked after addition Ly294002 indicating
that PI3- kinase activity mediated the GM-CSF effect. The
intracellular signaling that intermediates proliferative and
survival effects of GM-CSF have been previously cha-
racterized [42]. The proliferative effect is mediated by
activation of major tyrosine phosphorylation-dependent
signaling pathways including Jak/signal transducer and ac-
tivator of transcription, Ras/mitogen-activated protein
kinase, and PI3-kinase [43].
To estimate the effect of GM-CSF at the transcrip-
tion level we quantified the expression of IGF-2 in
bovine cumulus and oocytes after IVM. Our results
showed that IGF-2 expression in cumulus cells and
oocytes was not affected by GM-CSF treatment dur-
ing in vitro maturation. However, we found that IGF-
2 was up-regulated in cumulus cells and oocytes after
maturation. Moreover, IGF-2 expression increased in
oocytes and cumulus cells after maturation in TCM
compared to maturation in SOF or supplementation
with GM-CSF. Previous studies have suggested that
IGF-2 play an autocrine and paracrine role associated
to survival activity in embryos cultured under sub-
optimal conditions [44]. These data suggest that IGF-
2 expression may be modulated by culture conditions
but not by supplementation of GM-CSF.
We further tested the effect of GM-CSF on cumu-
lus expansion and the potential effect on oocyte com-
petence by evaluating the embryonic development of
COC matured with GM-CSF. Cumulus expansion has
been associated with several oocyte functions includ-
ing ovulation, cleavage and embryonic development
[24-26]. Cumulus cells also play an important role
during fertilization by stimulating sperm selection and
motility [25]. Using an in vitro system, oocytes treated
with and without GM-CSF were fertilized with fro-
zen/thawed semen and cultured in SOF for 9 days.
We found no differences among treatments on cleav-
age rate, blastocyst development and embryonic
nuclei count. These results indicate that the effect of
GM-CSF on cumulus expansion during maturation
was not sufficient to improve the subsequent embry-
onic development. Previous studies have showed that
addition of GM-CSF to culture media improved de-
velopment rates in bovine [45] and human [46] em-
bryos. Moreover, exposure of bovine [47] and human
[48] embryos to GM-CSF during development in-
creased the percentage that developed to term.Conclusions
In conclusion, both α- and β-subunits of the GM- CSF
receptor are expressed in bovine cumulus cells and oo-
cytes. Despite, GM-CSF enhanced cumulus cell expan-
sion of in vitro matured bovine COC, the oocyte nuclear
and cytoplasmic maturation, IGF-2 mRNA levels or
subsequent competence for embryonic development was
not affected by the GM-CSF treatment. Our data suggest
that GM-CSF may play a role in cumulus cell expansion
in vitro and increasing cell proliferation.
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